Cystic fibrosis nutrition: Addressing emerging trends following the 2024 ESPEN-ESPGHAN-ECFS guidelines. Expert
Chris Smith1, Sarah Collins2, Carla Colombo3
1Department of Nutrition and Dietetics, Royal Alexandra Children's Hospital, Brighton, United Kingdom; Brighton and Sussex Medical School, Brighton, United Kingdom.
Background:
Advancements in clinical care and scientific research in cystic fibrosis (CF) have transformed, and continue to shape, nutritional management and related practices. Front line clinicians delivering nutritional support require 'living guidelines' with regular updates to address emerging issues in the rapidly changing world of CF. In this paper we wish to provide context and framework recommendations on key issues that are becoming increasingly important in clinical practice where current international nutrition guidelines provide limited or no recommendations.
Methods:
The study was developed by an international multidisciplinary working group made up of previous authors of the ESPEN-ESPGHAN-ECFS 2024 guidelines. Key topics were identified and new internationally recognised expert authors were allocated to provide additional expertise as required. Statements were produced and a modified Delphi was used to gain consensus.
Results:
The working group developed recommendations to complement current guidelines on the quality of diet, the changes in pancreatic enzyme supplementation in the age of modulator therapy, evaluation and treatment of overweight and obesity, withdrawing tube feeding, nutritional support in cancer and nutrition care in older adults. These were endorsed by the ECFS Nutrition Group. The topics identified and examined in this paper represent issues that will need to be addressed in the next revision of the ESPEN-ESPGHAN-ECFS guideline. This paper therefore serves as a preliminary step in preparation for this update.
More Related Videos
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
07:38Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Kidney Disease III: Interprofessional Care
